Pre-market
Sale
Calculated transaction value
$70.43K

Kaiser Peter Chief Development Officer

Transaction date Oct 2, 2026
Public filing date Oct 6, 2026
Filing lag Filed 4 days later

OCUL daily price context

Close on/before transaction
$6.96 Oct 2, 2026
First close after public filing
$7.23 Oct 7, 2026
Return after filing · so far
+4.56% Through Oct 12, 2026

Source details

Reported owner
Not disclosed
Source asset code
Security
Security
Common Stock
Quantity / price
9,990 shares @ $7.05
SEC ownership
Direct
Transaction code
S
Form
4
Filing identifier
0001104659-26-114081
Filing cohort

Transactions in this filing

Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$70.43K
Buys / sales
0 / 1
Transactions reported in the same official filing
Issuer Transaction Traded Value
Ocular Therapeutix, Inc OCUL Current Sale Oct 2, 2026 $70.43K